Tescan announces that Carlyle, together with the other shareholders, has entered into a definitive agreement with Shimadzu Corporation for the sale of the company, resulting in a change in Tescan’s shareholding structure. The transaction is subject to regulatory approvals and further customary closing conditions.
Strategic Alignment in Advanced Analytical and Imaging Technologies
Shimadzu’s strengths in analytical and measuring technologies are highly complementary to Tescan’s advanced microscopy and imaging portfolio. The two companies already share a history of collaboration in scientific and industrial markets. This transaction reflects a strong alignment in mission, innovation focus, and long term commitment to scientific progress.
Statement from Tescan CEO
Jean Charles Chen, CEO of Tescan, said:
“Our people, our know-how, and our passion for innovation are the foundation of Tescan. This agreement signed by Carlyle and Shimadzu recognizes the strength of our teams and the value we create for customers. We will continue to focus on delivering advanced imaging solutions and supporting the evolving needs of the scientific and industrial communities.”
Business Continuity and Next Steps
During this period of closing, Tescan continues to operate as usual, remaining focused on every commitment to customers, partners, and distributors.
The official announcement from Carlyle provides further details about the transaction.
